Cargando…
Assessing the Effects of Acute Amyloid β Oligomer Exposure in the Rat
Alzheimer’s disease (AD) is the most common form of dementia, yet there are no therapeutic treatments that can either cure or delay its onset. Currently, the pathogenesis of AD is still uncertain, especially with respect to how the disease develops from a normal healthy brain. Amyloid β oligomers (A...
Autores principales: | Wong, Ryan S., Cechetto, David F., Whitehead, Shawn N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037670/ https://www.ncbi.nlm.nih.gov/pubmed/27563885 http://dx.doi.org/10.3390/ijms17091390 |
Ejemplares similares
-
The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012) -
Breaking the Code of Amyloid-β Oligomers
por: Lesné, Sylvain E.
Publicado: (2013) -
The Toxicity and Polymorphism of β-Amyloid Oligomers
por: Huang, Ya-ru, et al.
Publicado: (2020) -
Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013) -
Is there a sodium effect in fibrillar amyloid-β oligomers?
por: Horn, Anselm HC, et al.
Publicado: (2014)